New York State Common Retirement Fund Has $18.18 Million Stake in Humana Inc. $HUM

New York State Common Retirement Fund decreased its stake in shares of Humana Inc. (NYSE:HUM) by 3.8% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 74,362 shares of the insurance provider’s stock after selling 2,920 shares during the quarter. New York State Common Retirement Fund’s holdings in Humana were worth $18,180,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Norges Bank acquired a new stake in Humana during the second quarter worth about $397,079,000. Vanguard Group Inc. grew its holdings in shares of Humana by 8.9% during the 1st quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider’s stock worth $3,697,222,000 after purchasing an additional 1,143,662 shares in the last quarter. AQR Capital Management LLC increased its position in shares of Humana by 3,257.5% during the first quarter. AQR Capital Management LLC now owns 1,162,600 shares of the insurance provider’s stock valued at $307,624,000 after purchasing an additional 1,127,973 shares during the period. Leith Wheeler Investment Counsel Ltd. increased its position in shares of Humana by 661.7% during the second quarter. Leith Wheeler Investment Counsel Ltd. now owns 1,038,703 shares of the insurance provider’s stock valued at $253,942,000 after purchasing an additional 902,340 shares during the period. Finally, Nuveen LLC acquired a new position in shares of Humana in the first quarter valued at $171,220,000. Institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of HUM stock opened at $243.04 on Wednesday. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35. The stock has a market capitalization of $29.23 billion, a PE ratio of 18.65, a PEG ratio of 1.71 and a beta of 0.42. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The stock’s fifty day moving average is $262.58 and its 200-day moving average is $257.19.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.95 by $0.29. The business had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same period in the previous year, the business posted $4.16 earnings per share. Equities research analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, December 26th. This represents a $3.54 annualized dividend and a yield of 1.5%. Humana’s dividend payout ratio (DPR) is currently 33.18%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on HUM shares. Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a research note on Wednesday, October 8th. Wells Fargo & Company lifted their target price on shares of Humana from $344.00 to $347.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Truist Financial dropped their price target on shares of Humana from $300.00 to $285.00 and set a “hold” rating for the company in a research report on Monday, November 10th. Bank of America raised their price target on shares of Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a research note on Friday, October 10th. Finally, Sanford C. Bernstein upped their price objective on Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a research note on Friday, September 5th. Eight analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $295.94.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.